跳至主要内容
临床试验/JPRN-jRCTs031180371
JPRN-jRCTs031180371已完成2 期

An exploratory trial of betaine supplementation in patients with schizophrenia - An exploratory trial of betaine supplementation in patients with schizophrenia

Kasai Kiyoto0 个研究点目标入组 30 人开始时间: 2019年3月18日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 64age old(—)
性别
All

入选标准

  • 1) Diagnosed as schizophrenia based on DSM-IV-TR
  • 2) Written informed consent after a detailed explanation of this study

排除标准

  • 1) History of allergy to drugs
  • 2) History of substance use disorder
  • 3) High risk of suicide or other-injuring behavior
  • 4) No agreement with contraception during participation of this study
  • 5) Comorbidity or history of serious physical diseases
  • 6) Organic brain disorder requiring treatment
  • 7) Infection with HIV or hepatitis virus
  • 8) Serious abnormality of vital sign, laboratory data, or electrocardiogram
  • 9) Involuntarily hospital admission
  • 10) Restriction of behavior
  • 11) No disease notification
  • 12) Electroconvulsive therapy or transcranial magnetic stimulation within 3 months before participation of this study
  • 13) History of betaine use
  • 14) Use of investigational drug within 3 months before participation of this study
  • 15) More than 500 micromol/L of plasma methionine level
  • 16) Doctor's decision

研究者

发起方
Kasai Kiyoto

相似试验

A clinical trial of betaine in schizophrenia | 临床试验